The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (10 analysts) rates it strong buy, with a mean price target of $7. Insiders have been net buyers over the past quarter.
CI&T Inc
CINT · the NYSE · USD · Market cap $411M · 8,015 employees
CI&T Inc., together with its subsidiaries, provides strategy, design, and software engineering services in North America, Europe, Latin America, Asia Pacific, and worldwide.
PASS · Titan Ethical · score 70.0Price as of 4 Nov 2026Daily close, not a live quote
Screened 2026-11-04 · the tape above runs as of 16:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price3.10 USD at the 4 Nov 2026 close
- Fair valueUnder review: our model's value is 2.02x the price, above our 2.00x limit.
- Our regime readMarkdown, as of 4 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- Last reviewed4 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-04).
- Trend Markdown
- Insiders insiders bought, latest filing 2026-10-09
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
CI&T Inc holds its Markdown at $3.10. Consolidating, no directional conviction, held for 1 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 1 days |
| Price at the screen | $3.10 |
| Valuation | 11.46 trailing · 7.20 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.82 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 23.78% | Below 33% | Interest-bearing debt is just 23.8% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 26.71% | Below 49% | Money owed to the company is 26.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.22% | Below 5% | Only 0.2% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Clears, in Plain English
CI&T clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 24%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CINT's ethical verdict changes
Today CINT passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value under review. Our model's value is 2.02x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets: 10 covering, consensus Buy. The average target sits +61% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 7.2xcheap for a company growing this fast |
| Trailing P/E | 11.5xreasonably valued |
| EPS, trailing | 0.28 |
| EPS, forward | 0.45 |
| Revenue growth | +21.9%strong top-line growth |
| Profit margin | 6.8%thin but positive margins |
| Return on equity | 11.7%a modest return on shareholder capital |
| FCF yield | 4.92% |
| Debt to equity | 0.44minimal debt: a conservative balance sheet |
| Current ratio | 1.32adequate liquidity, worth monitoring |
| Beta | 0.82steadier than the market |
| Short interest, float | 0.00% |
| 52-week range | 2.80 - 5.80 |
| Moat | NONE |
| Market cap | $411M |
| Employees | 8,015 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Brazil and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCINT trades on the NYSE (the company is based in Brazil). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (10 analysts) rates it strong buy, with a mean price target of $7. Insiders have been net buyers over the past quarter.
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (10 analysts) rates it strong buy, with a mean price target of $7. Insiders have been net buyers over the past quarter.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 1.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (10 analysts) rates it strong buy, with a mean price target of $7. Insiders have been net buyers over the past quarter.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 14.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (10 analysts) rates it strong buy, with a mean price target of $7. Insiders have been net buyers over the past quarter.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 14.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (10 analysts) rates it strong buy, with a mean price target of $7.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 20.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (10 analysts) rates it strong buy, with a mean price target of $7.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 32%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (10 analysts) rates it strong buy, with a mean price target of $7.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- CI&T To Announce Third Quarter 2026 Results on November 11, 2026 Yahoo Finance · 9d ago
- Over 50 Projects with Claude Take CI&T to a New Partnership Tier Yahoo Finance · 22d ago
- UK Payments Industry Backs the National Payments Vision, but Only 29% Are Very Confident It Will Work, Finds CI&T Research Yahoo Finance · 10 Sep 2026
- CI&T (CINT) Q2 2026 Earnings Call Transcript Motley Fool · 19 Aug 2026
- CI&T (CINT) Q2 2026 Earnings Call Transcript Yahoo Finance · 19 Aug 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-09 | Martins Fernando Matt Borges | Dir, 10% | P - Purchase | 132 | $407 |
| 2026-09-25 | Gon Cesar Nivaldo | CEO, 10% | P - Purchase | 8,816 | $25,531 |
| 2026-10-06 | Martins Fernando Matt Borges | Dir, 10% | P - Purchase | 15,745 | $49,323 |
| 2026-10-01 | Martins Fernando Matt Borges | Dir, 10% | P - Purchase | 4,123 | $13,111 |
| 2026-09-29 | Gon Cesar Nivaldo | CEO, 10% | P - Purchase | 6,684 | $20,145 |
| 2026-09-29 | Guicardi Neto Bruno | Pres of N. Am. , Europe Ops, 10% | P - Purchase | 2,825 | $8,410 |
| 2026-09-24 | Guicardi Neto Bruno | Pres of N. Am., Europe Ops, 10% | P - Purchase | 581 | $1,755 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-06-02 | Gil Cisneros | Democrat | sell | 500K–1M |
| 2026-05-27 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-05-22 | Josh Gottheimer | Democrat | sell | 1K–15K |
| 2026-04-13 | Josh Gottheimer | Democrat | buy | 1K–15K |
| 2024-05-03 | Tommy Tuberville | Republican | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $3.99 | -0.3% | · | $998 | -0.3% |
| 2 months | $4.62 | -13.9% | · | $862 | -13.9% |
| 3 months | $5.50 | -27.6% | · | $724 | -27.6% |
| 6 months | $4.51 | -11.8% | · | $883 | -11.8% |
| 1 year | $5.88 | -32.3% | · | $677 | -32.3% |
| 2 years | $4.77 | -16.6% | · | $834 | -16.6% |
| 3 years | $5.33 | -25.3% | · | $747 | -25.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CINT does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.